Current therapeutic products legislation projects

To stay abreast of societal, technological, political and economic developments, the Therapeutic Products Legislation is continually being updated. The following legislative projects are currently in progress:

Ordinary Revision of the TPA and right of enforcement

The modifications following the Ordinary Revision of the TPA (Stage 2) and its right of enforcement entered into force on 1 January 2019. This will simplify the population's access to medicinal products and improve the conditions for biomedical research and industry.

Total revision of MPLO and Falsified Medicines Directive

Legislative changes in connection with the implementation of the Medicrime Convention and the provisions of the revised MPLO entered into force on 1 January 2019. This will improve the safety of medicines.

Revision of medical devices legislation

The safety and quality of medical devices will be improved. Switzerland is comprehensively revising its medical devices legislation in close correlation with the new EU regulations for medical devices.

Therapeutic products: integrity, transparency and discounts

Parliament and the Federal Council are redefining the rules governing material benefits. The transparency requirements on the purchase of therapeutic products are also being made more stringent.

Legislation

Medicinal products and medical devices legislation

The legislation on therapeutic products comprises the Federal Act on Medicinal Products and Medical Devices (TPA) and the associated ordinances. It is regularly aligned to the state of scientific and technical knowledge.

Last modification 26.09.2018

Top of page

Contact

Federal Office of Public Health FOPH
Division of Biomedicine
Therapeutic Products Law Section
Schwarzenburgstrasse 157
3003 Berne
Switzerland
Tel. +41 58 463 51 54
E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/medizin-und-forschung/heilmittel/aktuelle-rechtsetzungsprojekte.html